Gene Query: LAGE3

Dataset Description Geneva Score
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 33.73
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 23.12
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 18.3
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 18.3
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 17.84
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 16.45
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 14.38
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 14.06
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 13.57
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 13.47
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 13.42
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 12.97
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 12.78
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 12.69
Comprehensive comparative analysis of 5’ end RNA sequencing methods 12.69
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 12.56
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 12.48
Regulation of highly expressed hCINAP on translatome 11.93
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 11.77
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 11.48
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 10.38
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 10.0
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 9.99
Global analysis of enhancer targets: Mosaic-seq 9.88
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 9.76
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 9.62
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 9.6
Impact of dieldrin on transcription in Jurkat T cells 9.59
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 9.58
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 9.58
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 9.49
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 9.47
Patient-derived luminal breast cancer xenografts with progestins 9.09
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 9.09
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 8.92
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 8.88
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 8.88
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 8.83
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 8.83
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 8.83
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 8.56
DART-seq: an antibody-free method for global m6A detection 8.46
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 7.97
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 7.96
scRNASeq analysis of cycling cardiomyocytes 7.95
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 7.94
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 7.92
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 7.92
Generating Patterned Kidney Organoids for Studying Development and Diseases 7.9
Glioblastoma stem cells infected by ZIKA virus 7.81
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 7.8
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 7.77
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 7.6
Transcriptome of U251 cells overexpression complement component 7 7.58
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 7.24
The comparison of high-throughput single-cell RNA-seq methods 7.24
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 7.11
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 6.85
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 6.84
Conservative alteration of chromosomal expression pattern across human solid tumor types 6.8
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 6.63
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 6.63
LNCaP treated with iBET 6.62
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 6.57
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 6.56
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 6.51
Identification of transcription start sites for human A549 cell line using ReCappable-seq 6.51
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 6.41
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 6.41
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 6.36
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 6.27
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 6.26
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 6.25
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 6.2
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 6.17
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 6.17
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 6.06
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 6.06
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 6.05
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 6.0
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 6.0
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 5.93
Spliceosomal disruption of the non-canonical BAF complex in cancer 5.84
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 5.79
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 5.78
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 5.66
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 5.66
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 5.66
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 5.61
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 5.55
HNF1A deficiency impairs β-cell fate, granule maturation and function 5.54
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 5.49
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 5.39
Human Treg IL-12 stimulation 5.36
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 5.29
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 5.17
The Human Testis Cell Atlas via Single-cell RNA-seq 5.15
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 5.12
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 5.12
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 5.12
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 5.11
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 5.09
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 5.09
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 5.08
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 5.08
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 5.07
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 5.07
Systematic discovery of endogenous human ribonucleoprotein complexes 5.06
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 5.06
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 4.97
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 4.9
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 4.9
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 4.85
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 4.84
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 4.84
RNAseq of cell lines with knocked in ESR1 mutations 4.75
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 4.75
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 4.65
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 4.62
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 4.62
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 4.62
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 4.57
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 4.55
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 4.53
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 4.52
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 4.52
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 4.5
High-throughput sequencing of pluripotent cells 4.49
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 4.48
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 4.48
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 4.47
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 4.42
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 4.36
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 4.32
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 4.22
Tracking of dCas9-methyltransferase footprints 4.2
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 4.16
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 4.11
Tracking distinct RNA populations using efficient and reversible covalent chemistry 4.1
CSL 4.08
CSL RNA-Seq on HKC and SCC cell lines 4.08
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 4.04
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 3.98
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 3.94
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 3.94
Active translatome profiling with RiboLace in MCF7 cells 3.94
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 3.93
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 3.91
SUV420H2 knockdown in PANC-1 3.9
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 3.9
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 3.86
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 3.86
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 3.84
FOXD3 is a novel tumor suppressor in lung cancer 3.81
Interaction between mitoNEET and NAF-1 in cancer cells 3.8
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 3.79
The transcriptome effect of overexpressing EZH2 in MCF7 3.79
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 3.78
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 3.78
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 3.77
TT-Seq captures the human transient transcriptome 3.76
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 3.72
Mapping interactions for the TNIP2 hub protein 3.72
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 3.7
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 3.7
Transcriptome sequencing of K-562 cells 3.63
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 3.6
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 3.6
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 3.6
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 3.57
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 3.57
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 3.57
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 3.56
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 3.55
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 3.49
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 3.49
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 3.48
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 3.44
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 3.41
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 3.41
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 3.41
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 3.37
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 3.37
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 3.37
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 3.36
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 3.34
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 3.34
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 3.32
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 3.32
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 3.3
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.28
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 3.27
Altering cancer transcriptomes using epigenomic inhibitors 3.27
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 3.26
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 3.22
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 3.22
TOP2B disturbed the quality of human oocytes with advanced maternal age 3.22
RNA-seq of naive and primed ES cells 3.17
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 3.15
Identification of global regulators of T-helper cell lineage specification 3.15
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 3.15
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 3.14
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 3.13
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 3.13
Silencing p300 in MCF7 cells to study expression and alternative splicing 3.12
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 3.1
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 3.06
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 3.05
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 3.0
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 2.98
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 2.98
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 2.98
SLAM-seq for K562 endogenous mRNA decay 2.96
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 2.96
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 2.96
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 2.96
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 2.96
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 2.94
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 2.94
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 2.94
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 2.89
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 2.89
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 2.88
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 2.85
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 2.85
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 2.82
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 2.82
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 2.82
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 2.81
EWSR1 influences alternative splicing through direct and indirect mechanisms 2.8
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.79
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.79
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 2.79
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 2.78
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 2.77
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 2.76
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 2.75
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 2.65
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 2.64
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 2.63
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 2.62
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 2.61
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 2.61
Gene expression profiling of leukemia cells following asparagine depletion 2.6
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 2.57
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 2.57
Non-coding regions are the main source of tumor-specific antigens [human] 2.57
Non-coding regions are the main source of tumor-specific antigens 2.57
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 2.55
Nutritional control of protein translation 2.55
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 2.54
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 2.5
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 2.49
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 2.49
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 2.48
Transcriptional profiling of microglia; current state of the art and future perspectives 2.46
hTERT promotes cell adhesion and migration independent of telomerase activity 2.43
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 2.42
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 2.42
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 2.41
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.41
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.41
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 2.4
The MEF2B Regulatory Network 2.4
The MEF2B Regulatory Network - RNA-seq data 2.4
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 2.37
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 2.36
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 2.35
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 2.34
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 2.32
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 2.32
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 2.31
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 2.3
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.25
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 2.25
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 2.23
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 2.2
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 2.15
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 2.15
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 2.14
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 2.14
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 2.12
Real-time observation of light-controlled transcription in living cells 2.11
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 2.1
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 2.1
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 2.06
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 2.06
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 2.05
Next Generation Sequencing of human SMA and healthy control Motor Neurons 2.03
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 2.03
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 2.02
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 2.0
RNA-Seq of PRMT1 overexpression ECA109 cells 1.99
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 1.96
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 1.96
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 1.95
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 1.94
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 1.94
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 1.93
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 1.9
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 1.86
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 1.82
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 1.81
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 1.81
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 1.78
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 1.77
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 1.77
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 1.77
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 1.77
Transcriptome landscape of HeLa response upon triamcinolone acetonide 1.74
Effect of ILF3 on translation during homeostasis and the antiviral response 1.73
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 1.72
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.69
Bone marrow derived human B cells [normal proB] 1.69
Transcriptome of EBV-infected gastric cancer cell lines 1.66
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 1.66
Silencing SPIB in attached and floating state of H1703 lung cancer cells 1.66
Characterization of parental and rociletinib-resistant derived H1975 cell lines 1.66
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 1.65
Cajal bodies are linked to genome conformation 1.64
Cajal bodies are linked to genome conformation [RNA-Seq] 1.64
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.62
Transcriptional dependencies in diffuse intrinsic pontine glioma 1.58
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 1.54
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 1.53
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 1.52
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 1.52
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 1.5
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.5
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.5
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 1.49
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 1.49
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.48
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 1.48
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 1.47
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 1.47
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 1.46
RNA-seq analysis of differentiating human erythroblasts 1.46
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 1.45
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 1.44
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 1.43
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.42
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 1.4
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 1.37
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 1.37
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 1.37
Energy Metabolism during Anchorage-Independence 1.37
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 1.36
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 1.36
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 1.36
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 1.35
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 1.32
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 1.31
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.31
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 1.29
CROP-Seq in Primary Human T Cells 1.29
Genetic-to-epigenetic Therapy for Pancreatic Cancer 1.28
Functional significance of the HIV-1 Tat signature amino acid residues 1.23
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 1.23
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 1.23
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 1.22
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.21
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.21
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 1.2
CD73 knockdown effect in pancreatic cancer cell lines 1.2
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 1.16
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 1.13
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.1
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.1
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 1.08
In situ CAPTURE of chromatin interactions by biotinylated dCas9 1.06
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 1.06
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 1.05
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 1.02
Mutational landscape of splicing genes and functional consequences across 33 cancer types 1.0
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.97
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.97
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.96
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 0.96
Copper Regulation of HIF-1 Transcription Activity 0.96
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 0.92
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.88
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.88
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 0.87
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.87
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.87
Human Treg NaCl stimulation 0.84
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 0.84
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 0.83
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.81
Single-cell analysis of adult human ovary using 10X genomics 0.8
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.79
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.79
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.78
KLF6-dependent transcription in renal cancer cells 0.77
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 0.76
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 0.75
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 0.74
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.73
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 0.73
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 0.73
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.73
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.73
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.72
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.71
AUF-1 affected genes in human skin cells 0.71
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 0.7
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 0.7
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.69
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.66
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.65
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 0.65
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 0.64
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.64
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.63
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.63
Gene expression analysis of breast cancer cell-lines 0.62
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.62
EWS-Fli and LNC regulated genes in comparison to GFP samples 0.61
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.61
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 0.6
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.6
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.59
Gene expression regulated by CSA and CSB in neuroblastoma cell line 0.58
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.57
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 0.56
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 0.55
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 0.55
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.55
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 0.54
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 0.54
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.53
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 0.52
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.49
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.49
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.49
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.48
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.48
Molecular Criteria for Defining the Naive Human Pluripotent State 0.48
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.47
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 0.46
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.43
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.39
quanTIseq: quantifying immune contexture of human tumors 0.39
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.38
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.38
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.36
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.36
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 0.34
Differential gene expression profiles in imatinib-resistant cell lines 0.34
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.33
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 0.33
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 0.33
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.3
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.3
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.29
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.27
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.27
NR2F2 study 0.26
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 0.26
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.24
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.23
The cohesin complex prevents Myc-induced replication stress 0.23
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.22
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.22
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.22
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 0.21
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.2
MCF-7 as a model for functional analysis of breast cancer risk variants 0.19
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 0.18
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.17
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.17
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.17
miRNAs affected by antagomiR-17 treatment 0.16
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.16
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.16
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 0.15
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 0.14
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.13
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.12
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.08
CUREfast: Accelerating research with families 0.06
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.06
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.06
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.06
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.06
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.05
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.04
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.04
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 0.04
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.04
H1609088 Human RNA-Sequencing 0.02
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.02
Exploring ILF2 regulatory genes by next-generation sequencing 0.01
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.01
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.01
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.0
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.0
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.0
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation